General form of registration statement for all companies including face-amount certificate companies

Company Background (Details Narrative)

v2.4.0.8
Company Background (Details Narrative) (USD $)
 0 Months Ended 3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended 93 Months Ended 1 Months Ended 9 Months Ended 1 Months Ended
Feb. 07, 2014
Jan. 03, 2014
Jun. 30, 2014
Jun. 30, 2013
Jun. 30, 2014
Jun. 30, 2013
Dec. 31, 2006
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2010
Dec. 31, 2009
Dec. 31, 2008
Dec. 31, 2007
Dec. 31, 2013
Feb. 05, 2014
May 31, 2013
May 31, 2006
Common Stock [Member]
Dec. 31, 2006
Common Stock [Member]
May 31, 2006
Series C Preferred Stock [Member]
May 31, 2006
Preferred Series A [Member]
May 31, 2006
Preferred Series B [Member]
May 31, 2006
Series C Preferred Stock [Member]
Mar. 24, 2006
Series C Preferred Stock [Member]
Issuance of common stock, shares                                   9,447,100 9,447,100          
Issuance of preferred stock                                       13,859,324 [1] 14,440,920 [1] 11,113,544 [1]    
Issuance of preferred stock issued additional                               30,420,148             704,225 [1] 704,225
Proceeds from issuance of common stock and warrants $ 3,923,100                                              
Issuance of common shares for cash, Shares 6,276,960                                              
Warrants issued 6,276,960                                              
Warrant exercise price per share $ 0.625 $ 0.625           $ 0.625             $ 0.625                  
Proceeds from issuance of notes payable   2,076,000           8,489,036                                
Aggregate principal amount of notes payable (issued Jan. 03, 2014) converted to common stock   2,076,000           8,489,036             8,489,036                  
Outstanding principal notes repaid in full                       500,000 55,000                      
Shares of Common Stock issued upon conversion of notes payable   3,353,437           14,446,777                                
Warrants issued upon conversion of notes payable (issued Jan. 03, 2014)   3,321,600           14,446,777                                
Stock options cancelled 15,290,486                                              
Exercise price of cancelled option $ 0.07                                              
Stock options issued in substitution of cancelled options 6,889,555                                              
Stock options issued in substitution of cancelled options, price per share $ 0.155                                              
Additional stock options issued purchase number of common stock 20,867,266                                              
Additional stock options issued purchase number of common stock, price per share $ 0.625                                              
Ownership interest               100.00%             100.00%   100.00%              
Net losses     (2,021,070) (907,229) (13,305,999) (1,501,521) (4,104,289) (4,361,165) (2,543,390) (1,879,940) (3,948,021) (1,451,711) (6,700,148) (7,908,993) (32,897,657)                  
Deficit accumulated during the development stage                 28,536,492                              
Cash in operating activities         $ (3,786,706) $ (2,012,990)   $ (4,127,761) $ (1,159,237)           $ (23,516,610)                  
[1] These shares were subsequently converted into 40,118,013 shares of Series A Preferred Stock.